ADA Scientific Sessions Recap—Day #5: Marlon Pragnell, Ph.D.
The ADA’s Scientific Sessions is completed! Here, with the post-day recap, is Marlon Pragnell, Ph.D., head of the complications program…
End-Stage Kidney Disease: A Possible Biomarker of 10-Year Risk—and Therapeutic Target—for People with T1D
In the United States, diabetic kidney disease, or DKD, is responsible for more than half of all new cases of…
